We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients.
- Authors
Kurt, Berkan; Buendgens, Lukas; Wirtz, Theresa H.; Loosen, Sven H.; Schulze-Hagen, Maximilian; Truhn, Daniel; Brozat, Jonathan F.; Abu Jhaisha, Samira; Hohlstein, Philipp; Koek, Ger; Weiskirchen, Ralf; Trautwein, Christian; Tacke, Frank; Hamesch, Karim; Koch, Alexander
- Abstract
Perilipin 2 (PLIN2) is a lipid droplet protein with various metabolic functions. However, studies investigating PLIN2 in the context of inflammation, especially in systemic and acute inflammation, are lacking. Hence, we assessed the relevance of serum PLIN2 in critically ill patients. We measured serum PLIN2 serum in 259 critically ill patients (166 with sepsis) upon admission to a medical intensive care unit (ICU) compared to 12 healthy controls. A subset of 36 patients underwent computed tomography to quantify body composition. Compared to controls, serum PLIN2 concentrations were elevated in critically ill patients at ICU admission. Interestingly, PLIN2 independently indicated multiple organ dysfunction (MOD), defined as a SOFA score > 9 points, at ICU admission, and was also able to independently predict MOD after 48 h. Moreover, serum PLIN2 levels were associated with severe respiratory failure potentially reflecting a moribund state. However, PLIN2 was neither a predictor of ICU mortality nor did it reflect metabolic dysregulation. Conclusively, the first study assessing serum PLIN2 in critical illness proved that it may assist in risk stratification because it is capable of independently indicating MOD at admission and predicting MOD 48 h after PLIN2 measurement. Further evaluation regarding the underlying mechanisms is warranted.
- Subjects
CRITICALLY ill; PERILIPIN; COMPUTED tomography; INTENSIVE care units; MEDICAL care
- Publication
Biomedicines, 2021, Vol 9, Issue 9, p1210
- ISSN
2227-9059
- Publication type
Article
- DOI
10.3390/biomedicines9091210